ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · IEX Real-Time Price · USD

0.247

+0.012 (5.11%)

At close: Apr 19, 2024, 4:00 PM

0.246

-0.001 (-0.24%)

After-hours: Apr 19, 2024, 5:11 PM EDT

ENDRA Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-10.06	-13.18	-11.35	-12.12	-17.53	-9.8	-5.38	-2.78	-2.28
Depreciation & Amortization	0.28	0.23	0.22	0.17	0.12	0.07	0.06	0.06	0.07
Share-Based Compensation	1	1.2	1.44	2.1	1.4	1.37	1	0.23	0
Other Operating Activities	-0.76	-1.02	-1.56	-1.29	3.2	0.66	1.01	1.16	1.36
Operating Cash Flow	-9.55	-12.77	-11.12	-10.75	-8.59	-7.7	-3.3	-1.32	-0.84
Capital Expenditures	-0.02	-0.2	-0.05	-0.08	-0.04	-0.1	-0.01	0	-0.13
Investing Cash Flow	-0.02	-0.2	-0.05	-0.08	-0.04	-0.1	-0.01	0	-0.13
Share Issuance / Repurchase	6.5	8.4	10.62	6.78	0.13	7.74	8.59	0.01	0.84
Debt Issued / Paid	0	0	0	0.34	2.49	0.94	0.18	1.44	0
Other Financing Activities	1.01	-	2.79	4.76	5.72	-	-	-	-
Financing Cash Flow	7.52	8.4	13.4	11.88	8.34	8.67	8.77	1.44	0.84
Net Cash Flow	-2.06	-4.57	2.23	1.05	-0.3	0.87	5.46	0.13	-0.14
Free Cash Flow	-9.57	-12.97	-11.17	-10.82	-8.63	-7.8	-3.31	-1.32	-0.98
Free Cash Flow Margin	-	-	-	-	-	-126376.43%	-941.00%	-255.17%	-69.25%
Free Cash Flow Per Share	-1.50	-4.49	-5.46	-11.28	-23.02	-34.64	-24.00	-36.38	-8.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).